HIV medications produced by generic Indian manufacturer Ranbaxy Laboratories Ltd. will not be purchased under the President’s Emergency Plan for AIDS Relief (PEPFAR) until the company resolves U.S. Food and Drug Administration (FDA) violations at two of its plants, Bloomberg reports.
The program, which provides antiretroviral (ARV) medications to developing countries, will suspend funding for three Ranbaxy drugs: zidovudine, lamivudine and nevirapine.
According to the article, Ranbaxy has made efforts to improve conditions at one of its plants and, according to spokesman Charles M. Caprariello, is working with the U.S. government “to resolve all of the issues and concerns that have been raised.”
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
"I am psychologically suffering from body wasting, mainly hips, face, legs and arms. Does anyone know where I can order something (maybe underwear with foam) to fill the sunken hips, so that pants can start looking normal? I feel pathetic when I look at myself in the mirror in jeans—jeans used to fill up so nicely, now they just hang!"
